Human Interest
Pfizer says its pill prevents severe illness, should work against Omicron variant
On Tuesday, Pfizer announced that its Covid pill saw success in preventing severe disease during clinical trials and is predicted to work against the Omicron variant as well.
According to the New York Times, health care workers are hoping this new treatment could ease the burden of the looming fourth wave of Covid-19 infections. With the promising results from the clinical trials, it is possible the Food and Drug Administration will approve the drug in the coming days.
If approved, patients may receive the treatment by the end of the year, in limited supply. Data from the clinical trials show that the antiviral pill reduced the risk of hospitalization and death by 88% when given to unvaccinated people who are at a higher risk of severe illness within five days of the start of symptoms.
Sara Cherry, a virologist at the Perelman School of Medicine, said, “This is quite amazing and potentially transformative. If we could keep people out of hospitals, that would have a huge impact on health care.”
This comes just after the CDC warned of a tidal wave of infections from the Omicron and Delta variants coming within the next month.
The recent results are based on an analysis of over 2,200 unvaccinated individuals who are at a higher risk of severe disease. The study showed that 0.7% of patients who received the antiviral drug, Paxlovid, were hospitalized within 28 days of starting the trial with no deaths. However, 6.5% of those who received the placebo were hospitalized or died.
Despite the trial’s success, health care providers are faced with some obstacles once the drug becomes available. Patients will need both a positive coronavirus test and a prescription for Paxlovid all within five days of developing symptoms.
Terry A. Hurlbut has been a student of politics, philosophy, and science for more than 35 years. He is a graduate of Yale College and has served as a physician-level laboratory administrator in a 250-bed community hospital. He also is a serious student of the Bible, is conversant in its two primary original languages, and has followed the creation-science movement closely since 1993.
-
Education5 days ago
CHAPTER 11: Critical Race Theory: A Species of the Ideological Thought Genus Marxism
Space Is No Longer the Final Frontier—Reality Is [forthcoming release May 2024] -
Civilization4 days ago
CHAPTER 12: Seeding Race Wars
Space Is No Longer the Final Frontier—Reality Is [forthcoming release May 2024] -
Civilization4 days ago
Will Trump flip New York?
-
Education3 days ago
Title IX revision sparks State revolts
-
Constitution2 days ago
Precinct Strategy scores again
-
Clergy5 days ago
Historical Points Have Their Place, But That Is Not Where Your Faith Is To Stand!
-
Education4 days ago
Did the Freemasons, Illuminati, Spiritualists and Mystics establish this country?
-
Civilization1 day ago
Legacy media already assume Trump wins